Literature DB >> 26430729

Tdap vaccine attitudes and utilization among pregnant women from a high-risk population.

Amanda F Dempsey1, Sarah E Brewer1, Carter Sevick1, Jennifer Pyrzanowski1, Sara Mazzoni2, Sean T O'Leary1.   

Abstract

Infants infected with Bordatella pertussis experience high morbidity and significant mortality. Vaccinating pregnant mothers with the tetanus-diphtheria-acellular pertussis (Tdap) vaccine is a recommended strategy for preventing infant pertussis. This is especially important for mothers living in poverty and from racial and ethnic minority populations as these groups are at increased risk of having a pertussis-affected infant. Using the Health Belief Model as a framework, we surveyed a convenience sample of pregnant mothers representing these high-risk populations to understand factors associated with Tdap vaccine uptake during their pregnancy. Among the 316 mothers surveyed, 82% had gotten or planned to get Tdap that same day even though 63% of the sample had concerns about the safety of the vaccine during pregnancy. Perceived benefits and norms were the Health Belief Model constructs most consistently associated with Tdap vaccination. Although 32% of women reported prior Tdap vaccine receipt, this factor was not associated with Tdap vaccination during the current pregnancy, contrasting studies of vaccination done in non-pregnant populations. Important variations in attitudes were apparent, with Spanish-speaking women significantly more likely to have concerns about the vaccine's safety and efficacy than English-speaking women. This study indicates that among this high-risk population acceptance of Tdap vaccine during pregnancy is high. However, our results suggest that it may be important to modify information conveyed about the safety and importance of Tdap during pregnancy based on individual level factors such as language or acculturation.

Entities:  

Keywords:  Tetanus-diphtheria-acellular pertussis vaccine; cocooning; immunization; pregnancy

Mesh:

Substances:

Year:  2015        PMID: 26430729      PMCID: PMC4962928          DOI: 10.1080/21645515.2015.1094594

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  35 in total

1.  Formative research on HPV vaccine acceptability among Latina farmworkers.

Authors:  John S Luque; Heide Castañeda; Dinorah Martinez Tyson; Natalia Vargas; Cathy D Meade
Journal:  Health Promot Pract       Date:  2011-08-31

2.  Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany.

Authors:  Birte Bödeker; Dietmar Walter; Sabine Reiter; Ole Wichmann
Journal:  Vaccine       Date:  2014-06-10       Impact factor: 3.641

3.  What predicts postpartum pertussis booster vaccination? A controlled intervention trial.

Authors:  Elizabeth Helen Hayles; Spring Chenoa Cooper; Nicholas Wood; John Sinn; S Rachel Skinner
Journal:  Vaccine       Date:  2014-11-07       Impact factor: 3.641

4.  Influenza and pertussis vaccination coverage in pregnant women.

Authors:  Jolien Laenen; Mathieu Roelants; Roland Devlieger; Corinne Vandermeulen
Journal:  Vaccine       Date:  2015-03-18       Impact factor: 3.641

5.  Pregnant women's intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey.

Authors:  K E Wiley; P D Massey; S C Cooper; N Wood; H E Quinn; J Leask
Journal:  Vaccine       Date:  2013-06-15       Impact factor: 3.641

6.  Acceptability of a hypothetical group B strep vaccine among pregnant and recently delivered women.

Authors:  Amanda F Dempsey; Jennifer Pyrzanowski; Meghan Donnelly; Sarah Brewer; Juliana Barnard; Brenda L Beaty; Sara Mazzoni; Sean T O'Leary
Journal:  Vaccine       Date:  2014-03-21       Impact factor: 3.641

7.  Infant pertussis: who was the source?

Authors:  Kristine M Bisgard; F Brian Pascual; Kristen R Ehresmann; Claudia A Miller; Christy Cianfrini; Charles E Jennings; Catherine A Rebmann; Julie Gabel; Stephanie L Schauer; Susan M Lett
Journal:  Pediatr Infect Dis J       Date:  2004-11       Impact factor: 2.129

8.  Vaccination with tetanus, diphtheria, and acellular pertussis vaccine of pregnant women enrolled in Medicaid--Michigan, 2011-2013.

Authors:  Michelle Housey; Fan Zhang; Corinne Miller; Sarah Lyon-Callo; Jevon McFadden; Erika Garcia; Rachel Potter
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-09-26       Impact factor: 17.586

9.  Pertussis epidemic--California, 2014.

Authors:  Kathleen Winter; Carol Glaser; James Watt; Kathleen Harriman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-12-05       Impact factor: 17.586

10.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-22       Impact factor: 17.586

View more
  14 in total

1.  Clinician perspectives on strategies to improve patient maternal immunization acceptability in obstetrics and gynecology practice settings.

Authors:  Paula M Frew; Laura A Randall; Fauzia Malik; Rupali J Limaye; Andrew Wilson; Sean T O'Leary; Daniel Salmon; Meghan Donnelly; Kevin Ault; Matthew Z Dudley; Vincent L Fenimore; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2018-02-15       Impact factor: 3.452

2.  Knowledge attitude and practice toward pertussis vaccination during pregnancy among pregnant and postpartum Italian women.

Authors:  Eleonora Agricola; Francesco Gesualdo; Lia Alimenti; Elisabetta Pandolfi; Emanuela Carloni; Angelo D'Ambrosio; Luisa Russo; Ilaria Campagna; Beatrice Ferretti; Alberto E Tozzi
Journal:  Hum Vaccin Immunother       Date:  2016-08-02       Impact factor: 3.452

Review 3.  Efficacy and safety of pertussis vaccination for pregnant women - a systematic review of randomised controlled trials and observational studies.

Authors:  Marie Furuta; Jacqueline Sin; Edmond S W Ng; Kay Wang
Journal:  BMC Pregnancy Childbirth       Date:  2017-11-22       Impact factor: 3.007

Review 4.  Pertussis vaccination in pregnancy.

Authors:  C Mary Healy
Journal:  Hum Vaccin Immunother       Date:  2016-07-06       Impact factor: 3.452

Review 5.  Barriers and Facilitators Associated With Vaccine Acceptance and Uptake Among Pregnant Women in High Income Countries: A Mini-Review.

Authors:  Xiao Qiu; Heather Bailey; Claire Thorne
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

6.  Vaccine uptake and barriers to vaccination among at-risk adult populations in the US.

Authors:  Irina Kolobova; Mawuli Kwame Nyaku; Anna Karakusevic; Daisy Bridge; Iain Fotheringham; Megan O'Brien
Journal:  Hum Vaccin Immunother       Date:  2022-05-10       Impact factor: 4.526

7.  "When you are injected, the baby is protected:" Assessing the acceptability of a maternal Tdap vaccine based on mothers' knowledge, attitudes, and beliefs of pertussis and vaccinations in Lusaka, Zambia.

Authors:  Anna Larson Williams; Lois McCloskey; Magdalene Mwale; Lawrence Mwananyanda; Kenya Murray; Augusta R Herman; Donald M Thea; William B MacLeod; Christopher J Gill
Journal:  Vaccine       Date:  2018-04-10       Impact factor: 3.641

8.  Influenza and pertussis vaccination in pregnancy: Portrayal in online media articles and perceptions of pregnant women and healthcare professionals.

Authors:  Christopher R Wilcox; Kathryn Bottrell; Pauline Paterson; William S Schulz; Tushna Vandrevala; Heidi J Larson; Christine E Jones
Journal:  Vaccine       Date:  2018-11-03       Impact factor: 3.641

9.  Intention to Accept Pertussis Vaccination for Cocooning: A Qualitative Study of the Determinants.

Authors:  Olga Visser; Jeannine L A Hautvast; Koos van der Velden; Marlies E J L Hulscher
Journal:  PLoS One       Date:  2016-06-02       Impact factor: 3.240

10.  Provider insight on surmounting specialty practice challenges to improve Tdap immunization rates among pregnant women.

Authors:  Arpita Mehrotra; Allison Kennedy Fisher; Jennifer Mullen; Leslie Rodriguez; Angela J Jiles; Alison P Albert; Laura A Randall; Paula M Frew
Journal:  Heliyon       Date:  2018-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.